High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern

SARS-CoV-2 variants of concern show reduced neutralization by vaccine-induced and therapeutic monoclonal antibodies; therefore, treatment alternatives are needed. We tested therapeutic equine polyclonal antibodies (pAbs) that are being assessed in clinical trials in Costa Rica against five globally...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreira-Soto, Andres, Arguedas, Mauricio, Brenes, Hebleen, Buján, Willem, Corrales-Aguilar, Eugenia, Díaz, Cecilia, Echeverri, Ann, Flores-Díaz, Marietta, Gómez, Aarón, Hernández, Andrés, Herrera, María, León, Guillermo, Macaya, Román, Kühne, Arne, Molina-Mora, José Arturo, Mora, Javier, Sanabria, Alfredo, Sánchez, Andrés, Sánchez, Laura, Segura, Álvaro, Segura, Eduardo, Solano, Daniela, Soto, Claudio, Stynoski, Jennifer L., Vargas, Mariángela, Villalta, Mauren, Reusken, Chantal B. E. M., Drosten, Christian, Gutiérrez, José María, Alape-Girón, Alberto, Drexler, Jan Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451950/
https://www.ncbi.nlm.nih.gov/pubmed/34552949
http://dx.doi.org/10.3389/fmed.2021.735853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451950/
https://www.ncbi.nlm.nih.gov/pubmed/34552949
http://dx.doi.org/10.3389/fmed.2021.735853

Ejemplares similares